| review article | Q7318358 |
| scholarly article | Q13442814 |
| P953 | full work available at URL | http://pharmrev.aspetjournals.org/cgi/content/abstract/43/4/425 |
| P698 | PubMed publication ID | 1775506 |
| P50 | author | Charles Nemeroff | Q5081224 |
| P2093 | author name string | Owens MJ | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| physiology | Q521 | ||
| P304 | page(s) | 425-473 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | Pharmacological Reviews | Q2085079 |
| P1476 | title | Physiology and pharmacology of corticotropin-releasing factor | |
| P478 | volume | 43 |
| Q86419589 | A Mutagenic Primer Assay for Genotyping of the CRHR1 Gene Rare Variant rs1876828 (A/G) in Asians: A Cost-Effective SNP Typing |
| Q34577659 | A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor |
| Q55058368 | A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health. |
| Q34311076 | A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle |
| Q37080576 | Addiction and arousal: the hypocretin connection. |
| Q52049859 | Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats. |
| Q36789604 | Alpha-melanocyte-stimulating hormone attenuates behavioral effects of corticotropin-releasing factor in isolated guinea pig pups |
| Q35658052 | Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice |
| Q36708003 | Altered emotional and locomotor responses in mice deficient in the transcription factor CREM |
| Q36309244 | Amylin blunts hyperphagia and reduces weight and fat gain during recovery in socially stressed rats. |
| Q85370900 | Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential |
| Q38695316 | Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system. |
| Q33837383 | Association analysis of the glucocorticoid receptor gene (NR3C1) haplotypes (ER22/23EK, N363S, BclI) with mood and anxiety disorders in patients with asthma |
| Q35925007 | Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome |
| Q43714569 | Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressin receptor V3 and corticotropin-releasing factor receptor 1 messenger ribonucleic acids in the anterior pituitary of endotoxemic steers |
| Q36600274 | Behavioral effects of peripheral corticotropin-releasing factor during maternal separation may be mediated by proinflammatory activity |
| Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
| Q37111899 | Biological basis of suicide and suicidal behavior |
| Q51967120 | Blockade of corticoliberin receptors prevents the development of post-stress psychopathology in rats with an active strategy of adaptive behavior. |
| Q30494303 | CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling |
| Q42618279 | CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats. |
| Q48710657 | CRH-R1 and CRH-R2 differentially modulate dendritic outgrowth of hippocampal neurons |
| Q30514236 | Central CRF system perturbation in an Alzheimer's disease knockin mouse model. |
| Q42009557 | Central adrenal insufficiency and diabetes insipidus misdiagnosed as severe depression |
| Q33624771 | Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies |
| Q36381383 | Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer |
| Q35766585 | Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction |
| Q26851378 | Childhood stressful events, HPA axis and anxiety disorders |
| Q52712187 | Chlorpyrifos induced region specific vulnerability in rat CNS and modulation by age and cold stress: an interactive study. |
| Q42482798 | Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. |
| Q30430100 | Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse |
| Q36211439 | Class II G protein-coupled receptors and their ligands in neuronal function and protection |
| Q34740438 | Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. |
| Q42146632 | Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus |
| Q36161776 | Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF). |
| Q36073352 | Cold stress offered modulation on chlorpyrifos toxicity in aging rat central nervous system |
| Q48263316 | Colorectal distention induces acute and delayed visceral hypersensitivity: role of peripheral corticotropin-releasing factor and interleukin-1 in rats. |
| Q71687283 | Colorimetric assay for rapid screening of corticotropin releasing factor receptor ligands |
| Q36499178 | Comparing biobehavioral profiles across two social stress paradigms in children with and without autism spectrum disorders |
| Q28577858 | Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery |
| Q36596573 | Convergent regulation of locus coeruleus activity as an adaptive response to stress |
| Q46506794 | Corticotropin Releasing Factor in the Bed Nucleus of the Stria Terminalis in Socially Defeated and Non-stressed Mice with a History of Chronic Alcohol Intake |
| Q44386029 | Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety |
| Q73703050 | Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes |
| Q87910759 | Corticotropin-Releasing Hormone Binding Protein: Stress, Psychopathology, and Antidepressant Treatment Response |
| Q30451638 | Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses |
| Q44911149 | Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. |
| Q48686354 | Corticotropin-releasing factor and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing type II GR antisense ribonucleic acid |
| Q34536632 | Corticotropin-releasing factor critical for zebrafish camouflage behavior is regulated by light and sensitive to ethanol |
| Q37607547 | Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction |
| Q30459620 | Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility |
| Q73066542 | Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system |
| Q38473099 | Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. |
| Q30488089 | Corticotropin-releasing factor receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters. |
| Q85943965 | Corticotropin-releasing factor reduces tumor volume, halts further growth, and enhances the effect of chemotherapy in 4T1 mammary carcinoma in mice |
| Q42679658 | Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats |
| Q45128008 | Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. |
| Q39773059 | Corticotropin-releasing hormone excites adrenocorticotropin-secreting human pituitary adenoma cells by activating a nonselective cation current |
| Q33947439 | Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes. |
| Q37082749 | Corticotropin-releasing hormone receptor expression and functional signaling in murine gonadotrope-like cells |
| Q39258211 | Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans |
| Q37087511 | Cortisol and ACTH responses to the Dex/CRH test: influence of temperament |
| Q47903886 | Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression |
| Q37438547 | Current and novel therapeutic options for irritable bowel syndrome management |
| Q24633065 | Cytokines sing the blues: inflammation and the pathogenesis of depression |
| Q37517285 | Depression and antidepressants: molecular and cellular aspects. |
| Q36764298 | Depression and immunity: inflammation and depressive symptoms in multiple sclerosis |
| Q49139291 | Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitary |
| Q37231289 | Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? |
| Q35001759 | Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience-induced changes in hippocampal glucocorticoid receptor mRNA. |
| Q34489314 | Effect of Triphala on oxidative stress and on cell-mediated immune response against noise stress in rats |
| Q35596611 | Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome |
| Q71227095 | Effects of ACTH and ACTH 4-10 on aversive memory retrieval in rats |
| Q30450034 | Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety |
| Q33643281 | Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors |
| Q36228218 | Effects of psychologic stress on fetal development and pregnancy outcome |
| Q39085570 | Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor |
| Q30472177 | Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder |
| Q37710423 | Emerging role of alternative splicing of CRF1 receptor in CRF signaling. |
| Q30394985 | Endogenous Opioids: The Downside of Opposing Stress |
| Q30408911 | Endogenous opioids: opposing stress with a cost |
| Q37109740 | Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala |
| Q35827127 | Exploration of the Hypothalamic-Pituitary-Adrenal Axis to Improve Animal Welfare by Means of Genetic Selection: Lessons from the South African Merino |
| Q36460150 | Exposure to Chronic Mild Stress Differentially Alters Corticotropin-Releasing Hormone and Arginine Vasopressin mRNA Expression in the Stress-Responsive Neurocircuitry of Male and Female Rats Prenatally Exposed to Alcohol |
| Q48599930 | Extrahypothalamic corticoliberin receptors regulate the reinforcing effects of self-stimulation. |
| Q36965806 | Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors |
| Q37321242 | Functional CRH variation increases stress-induced alcohol consumption in primates |
| Q28241963 | GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response |
| Q36236640 | Glucocorticoid sensitizers Bag1 and Ppid are regulated by adolescent stress in a sex-dependent manner |
| Q38991472 | HPA Axis Interactions with Behavioral Systems |
| Q41501245 | Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides |
| Q28483614 | Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal |
| Q44293726 | Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration |
| Q35351250 | Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome |
| Q35790395 | Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression |
| Q34491885 | Induction and Expression of Fear Sensitization Caused by Acute Traumatic Stress |
| Q36439066 | Inhibition of neuronal nitric oxide reduces anxiety-like responses to pair housing |
| Q81152624 | Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response |
| Q72190599 | Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone |
| Q36514156 | Irritable bowel syndrome: recent and novel therapeutic approaches |
| Q64087792 | Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope? |
| Q60719548 | Localization of the corticotropin-releasing hormone receptor gene on mouse Chromosome 11 |
| Q27307634 | Long-lasting consequences of neonatal maternal separation on social behaviors in ovariectomized female mice |
| Q40650533 | Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. |
| Q33816520 | Mammary gene expression profiles during an intramammary challenge reveal potential mechanisms linking negative energy balance with impaired immune response |
| Q36060471 | Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site |
| Q36070060 | Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. |
| Q35430692 | Melatonin Attenuates Noise Stress-induced Gastrointestinal Motility Disorder and Gastric Stress Ulcer: Role of Gastrointestinal Hormones and Oxidative Stress in Rats |
| Q47207303 | Microbiota Modulate Anxiety-Like Behavior and Endocrine Abnormalities in Hypothalamic-Pituitary-Adrenal Axis |
| Q28478509 | Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish |
| Q47774058 | Modification of the behavioral effects of corticoliberin by early post-natal administration of corticosteroid hormones |
| Q35250463 | Molecular and cellular sex differences at the intersection of stress and arousal. |
| Q40918840 | Molecular biology of the regulation of hypothalamic hormones |
| Q37343344 | NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER. |
| Q34695129 | NEUROBIOLOGY OF ADULT AND TEENAGE SUICIDE |
| Q37364474 | Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events |
| Q39017236 | Neural Underpinnings of Decision Strategy Selection: A Review and a Theoretical Model. |
| Q37173485 | Neurobiology of suicidal behavior. An integration of biological and clinical findings |
| Q41508067 | Neuroendocrine mechanisms of the formation of adaptive behavior |
| Q37087117 | Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer |
| Q28069771 | Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress |
| Q34081783 | Neuropsychiatric adverse effects of interferon-alpha: recognition and management |
| Q21129366 | Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress |
| Q37072730 | Novel expression of type 1 corticotropin-releasing hormone receptor in multiple endocrine cell types in the murine anterior pituitary |
| Q34228120 | On the role of corticotropin-releasing hormone receptors in anxiety and depression |
| Q43171063 | On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders |
| Q40832553 | Overexpressing Corticotropin-Releasing Factor in the Primate Amygdala Increases Anxious Temperament and Alters Its Neural Circuit |
| Q24567741 | Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders |
| Q34726454 | Personalized medicine in psychiatry: problems and promises |
| Q47686059 | Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus |
| Q26830683 | Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms |
| Q35988500 | Pituitary CRH-binding protein and stress in female mice |
| Q48519599 | Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats. |
| Q37114415 | Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension |
| Q43653423 | Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. |
| Q42454582 | Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. |
| Q48823444 | Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. |
| Q40437410 | Regulation of adrenocorticotropic hormone secretion: lessons from mice deficient in corticotropin-releasing hormone |
| Q30498987 | Regulation of corticosteroid receptor gene expression in depression and antidepressant action |
| Q43578204 | Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. |
| Q47903674 | Relationships between trait and respiratory parameters during quiet breathing in normal subjects |
| Q42714025 | Relaxing actions of corticotropin-releasing factor on rat resistance arteries. |
| Q35020584 | Residues remote from the binding pocket control the antagonist selectivity towards the corticotropin-releasing factor receptor-1. |
| Q34294075 | Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system |
| Q47607724 | Sex differences in circuits activated by corticotropin releasing factor in rats |
| Q64276138 | Sex differences in corticotropin releasing factor regulation of medial septum-mediated memory formation |
| Q28583583 | Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology |
| Q36044962 | Sex differences in molecular and cellular substrates of stress. |
| Q36923878 | Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress |
| Q37071838 | Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation |
| Q37618519 | Sex-biased cellular signaling: molecular basis for sex differences in neuropsychiatric diseases |
| Q36627753 | Sexual dimorphism of stress response and immune/ inflammatory reaction: the corticotropin releasing hormone perspective |
| Q37328849 | Soluble corticotropin-releasing hormone receptor 2alpha splice variant is efficiently translated but not trafficked for secretion |
| Q34360801 | Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. |
| Q48378313 | Stable modifications to the expression of neurohormones in the rat hypothalamus in a model of post-traumatic stress disorder |
| Q36356595 | Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. |
| Q24622212 | Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression |
| Q41817875 | Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats |
| Q36409134 | Stress-induced changes in sleep in rodents: models and mechanisms |
| Q36372565 | Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons |
| Q24596885 | Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor |
| Q38567190 | Studying longitudinal trajectories in animal models of psychiatric illness and their translation to the human condition |
| Q42533202 | Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators |
| Q35894035 | Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor |
| Q38828768 | Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF |
| Q48202639 | T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty |
| Q35623039 | Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice |
| Q35748355 | Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults |
| Q35748330 | Temperament and response to the Trier Social Stress Test |
| Q30470848 | Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization |
| Q48274036 | The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal |
| Q92466384 | The behavioral and neurochemical effects of methylprednisolone or metyrapone in a post-traumatic stress disorder rat model |
| Q36871552 | The bladder-brain connection: putative role of corticotropin-releasing factor |
| Q37085120 | The central corticotropin releasing factor system during development and adulthood |
| Q28367946 | The effects of oral sumatriptan, a 5‐HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man |
| Q37696373 | The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention |
| Q30470629 | The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. |
| Q37574667 | The neurobiological toll of child abuse and neglect. |
| Q34178687 | The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review |
| Q36114372 | The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists. |
| Q30490519 | The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems |
| Q24623870 | The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome |
| Q28390650 | This can't be stressed enough: The contribution of select environmental toxicants to disruption of the stress circuitry and response |
| Q37621854 | Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior |
| Q38052337 | Translational reciprocity: bridging the gap between preclinical studies and clinical treatment of stress effects on the adolescent brain. |
| Q34270532 | Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects |
| Q35776014 | Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis |
| Q28581533 | Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I |
| Q35816431 | Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing |
| Q47835221 | Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat. |
| Q37740491 | What Kind of Stress Is Associated with Depression, Anxiety and Suicidal Ideation in Korean Employees? |
| Q34701742 | What can post-mortem studies tell us about the pathoetiology of suicide? |
| Q34919211 | Xiao Yao San Improves Depressive-Like Behaviors in Rats with Chronic Immobilization Stress through Modulation of Locus Coeruleus-Norepinephrine System |
| Q36764636 | [(76) Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor |
Search more.